HGP-30: The companies' Viral Technologies Inc. joint venture began an extension of a Phase I trial, for safely and to monitor immune memory responses in 15 HIV-

Alpha 1 Biomedicals Inc. (ALBM), Bethesda, Md. Cel-Sci Corp. (CELI), Alexandria, Va. Product: HGP-30, a synthetic copy of part of the p17 core protein of HIV Use: AIDS vaccine Status: The companies' ...